Serum zonulin in patients with inflammatory bowel disease: a pilot study
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In recent years it has been supposed that impaired intestinal permeability represents an early event preceding the onset of inflammatory bowel disease (IBD). Since zonulin has been proposed as a biomarker of intestinal permeability, we investigated its role in patients with IBD and the correlation between serum and fecal zonulin. METHODS: A total of 118 IBD patients (86 Crohn's disease [CD] and 32 ulcerative colitis [UC]) and 23 healthy controls (HC) were prospectively enrolled. A serum sample was collected for all the subjects included in the study. A stool specimen collected in the same day of blood drawing was available for a subgroup of 33 IBD patients. Serum and fecal zonulin were tested by ELISA. Non-parametric statistical tests were used for data analysis. RESULTS: Serum zonulin concentration was higher in IBD patients compared to HC (34.5 [26.5-43.9] ng/mL vs. 8.6 [6.5-12.0] ng/mL, P<0.001) showing an area under the curve of 0.98 for their discrimination. No difference in serum zonulin concentration was observed between patients with CD and those with UC (P=0.074). An inverse correlation was observed between serum zonulin concentration and disease duration (rs=-0.30, P=0.001); no correlation was observed between serum and fecal zonulin (rs=0.15, P=0.394). CONCLUSIONS: Serum zonulin is highly sensitive for the evaluation of intestinal permeability in IBD patients. There is no correlation between zonulin values in serum and feces.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Michielan, A., & D’Incà, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/628157 · Cited by 709 · cited 1×
“7 In the setting of IBD, it is supposed that impaired intestinal permeability represents an early event preceding disease onset.(8) The passage of non-self-antigens in the lamina propria may trigger the immune response mediated by cytokines such as interferon (IFN)-γ and tumor necrosis factor (TNF)-α which in turn may…”
BackgroundIntestinal barrier dysfunction in inflammatory bowel diseases
McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. J., & Radford-Smith, G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20539 · Cited by 627
Intestinal permeability and the prediction of relapse in Crohn's disease
Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626
Intestinal permeability and its regulation by zonulin: Diagnostic and therapeutic implications
Fasano, A. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.08.012 · Cited by 402
Sturgeon, C., Lan, J., & Fasano, A. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13343 · Cited by 82 · cited 1×
“transgenic mice model showed that increased intestinal permeability preluded the development of colitis only in the presence of an inflammatory trigger.(19)”
Background
Cited by
Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development
Ghosh, S. S., Wang, J., Yannie, P. J., & Ghosh, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz039 · Cited by 759
Fasano, A. (2020) · F1000Research · doi:10.12688/f1000research.20510.1 · Cited by 481
Rocha, I. M. G. D., Torrinhas, R., Fonseca, D., Lyra, C. D. O., de Sousa Alves Neri, J. L., Balmant, B. D., Callado, L., Charlton, K., Queiroz, N., & Waitzberg, D. L. (2023) · Nutrients · doi:10.3390/nu15194148 · Cited by 43
Serum zonulin and colorectal cancer risk
Marino, M., Mignozzi, S., Michels, K. B., Cintolo, M., Penagini, R., Gargari, G., Ciafardini, C., Ferraroni, M., Patel, L., Del Bo’, C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76697-z · Cited by 10
“However, another study based on 118 IBD patients and 23 healthy controls found higher serum zonulin concentrations in patients with Crohn’s disease and ulcerative colitis and an inverse correlation between serum zonulin concentration and disease duration 33 .”
Ranjan, K. (2020) · Gastrointestinal Disorders · doi:10.3390/gidisord2030024 · Cited by 6
Metadata
- Authors
- Caviglia, G. P., Dughera, F., Ribaldone, D. G., Rosso, C., Abate, M. L., Pellicano, R., Bresso, F., Smedile, A., Saracco, G. M., & Astegiano, M.
- Venue
- Minerva Medica
- Publisher
- Edizioni Minerva Medica
- Published
- 2019-02
- Volume
- 110
- Issue
- 2
- Pages
- 95-100
- ISSN
- 0026-4806 (ISSN-L)
- 1827-1669
- OpenAlex
- W2919196073
- Cited by
- 122
- References
- 6
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum zonulin in patients with inflammatory bowel disease: a pilot study. https://app.cochat.ai/papers/10.23736/s0026-4806.18.05787-7
- The paper
- Caviglia, G. P., Dughera, F., Ribaldone, D. G., Rosso, C., Abate, M. L., Pellicano, R., Bresso, F., Smedile, A., Saracco, G. M., & Astegiano, M. (2019). Serum zonulin in patients with inflammatory bowel disease: a pilot study. Minerva Medica. https://doi.org/10.23736/s0026-4806.18.05787-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.